Sai Life Sciences Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | December 11, 2024 to December 13, 2024 |
| Listing Date | - |
| Face Value | ₹ 1 per share |
| Price Band | ₹ 522 to ₹ 549 per share |
| Lot Size | 27 Shares |
| Total Issue Size | 5,54,21,123 shares (aggregating up to ₹ 3,042.62 Cr) |
| Fresh Issue | 1,73,04,189 shares (aggregating up to ₹ 950.00 Cr) |
| Offer for Sale | 3,81,16,934 shares of ₹1 (aggregating up to ₹ 2,092.62 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Shareholding pre issue | 19,06,85,340 |
| Shareholding post issue | 20,79,89,529 |
About Sai Life Sciences Limited IPO
Incorporated in January 1999, Sai Life Sciences Limited has established itself as a prominent player in the research, development, and manufacturing of small-molecule new chemical entities. The company is renowned for delivering tailor-made services to biotech firms and global pharmaceutical giants, effectively supporting their innovative pursuits.
In the Financial Year 2024, Sai Life Sciences demonstrated its extensive reach and expertise by providing services to over 280 innovator pharmaceutical companies. Remarkably, in September 2024 alone, the company collaborated with more than 230 clients, showcasing its capacity to handle a high volume of projects efficiently. Among these esteemed clients, Sai Life Sciences proudly counts 18 of the top 25 pharmaceutical companies, based on their revenue in the calendar year 2023, underlining its reputation and trustworthiness in the industry.
Sai Life Sciences has strategically expanded its services to key markets, including the US, the UK, Europe, and Japan, ensuring global accessibility and influence. The company’s business development team is composed of 16 highly experienced and qualified professionals, with six stationed in the US, nine in the UK and Europe, and one in Japan. This diverse and strategically located team enables Sai Life Sciences to cater to the specific needs of clients in different regions effectively.
The company’s core service offerings include capabilities in chemistry, manufacturing, and control (CMC), as well as contract development and manufacturing organizations (CDMO). Additionally, Sai Life Sciences provides comprehensive contract research organization (CRO) services, featuring integrated discovery capabilities across biology, chemistry, drug metabolism, and pharmacokinetics. This extensive range of services positions Sai Life Sciences as a versatile and indispensable partner for pharmaceutical innovation.
Sai Life Sciences Limited IPO Overview:
- Issue Type: Combination of fresh issue and offer for sale (OFS)
- IPO Size: ₹3,042.62 crores
- Subscription Dates: Opens on December 11, 2024 and closes on December 13, 2024
- Fresh Issue: ₹950.00 crores (1.73 crore shares)
- Offer for Sale: ₹2,092.62 crores (3.81 crore shares)
- Price Per Share: ₹522 to ₹549 per share
- Minimum Lot Size: 27 shares per application
- Book Running Lead Managers: Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Company Pvt Ltd and IIFL Securities Ltd.
- Registrar: Kfin Technologies Limited
Sai Life Sciences IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Sai Life Sciences IPO Objectives:-
- The company propose to utilise the Net Proceeds towards funding the following objectives:
- 1. Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company.
- 2. General corporate purposes.
Sai Life Sciences Limited IPO Financial Information
Latest Revenue
693.35
₹ Crore
Profit After Tax
28.01
₹ Crore
Net Worth
1,044.75
₹ Crore
Total Borrowing
764.49
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 30 Sep 2024 | 2,476.78 | 693.35 | 28.01 | 1,044.75 | 764.49 | ||||
| 31 Mar 2024 | 2,275.14 | 1,494.27 | 82.81 | 974.34 | 710.16 | ||||
| 31 Mar 2023 | 2,186.65 | 1,245.11 | 9.99 | 887.29 | 699.23 | ||||
| 31 Mar 2022 | 2,164.23 | 897.74 | 6.23 | 877.76 | 751.32 | ||||
| Amount in ₹ Crore | |||||||||
Sai Life Sciences Limited Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 11.79% |
| ROCE | 15.96% |
| RoNW | 8.13% |
| P/BV | 10.18 |
| PAT Margin (%) | 5.65 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.34 | 2.69 |
| P/E (x) | 126.42 | 203.82 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
As an integrated CRDMO, the company provides a complete platform for discovery, development and manufacturing.
CDMO platform with a diverse mix of commercial and under-development molecules.
CRO services include integrated discovery capabilities across biology, chemistry and drug metabolism and pharmacokinetics.
Download regulatory filings
Sai Life Sciences Limited IPO Timeline
| IPO Open Date | Wednesday, December 11, 2024 |
| IPO Close Date | Friday, December 13, 2024 |
| Basis of Allotment | Monday, December 16, 2024 |
| Initiation of Refunds | Tuesday, December 17, 2024 |
| Credit of Shares to Demat | Tuesday, December 17, 2024 |
| Listing Date | Wednesday, December 18, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 13, 2024 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351 | ₹192,699 |
| S-HNI (Min) | 14 | 378 | ₹207,522 |
| S-HNI (Max) | 67 | 1,809 | ₹993,141 |
| B-HNI (Min) | 68 | 1,836 | ₹1,007,964 |